Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1377789 | Bioorganic & Medicinal Chemistry Letters | 2007 | 4 Pages |
Abstract
A series of N-benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amine monoamine reuptake inhibitors are described. Selective dual 5-HT and NA reuptake inhibition was achieved, and analogues with weak CYP2D6 inhibition, good human in vitro metabolic stability and wide ligand selectivity, such as 12b, were identified.
Graphical abstractA series of amino-pyrrolidines with potent dual 5-HT/NA reuptake inhibition, good metabolic stability and weak CYP2D6 inhibition is described.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Paul V. Fish, M. Jonathan Fray, Alan Stobie, Florian Wakenhut, Gavin A. Whitlock,